Project Grant HT9425261E016
Award Date 5/1/26
Completion Date 4/30/29
Dollars Obligated $750K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- Federal Grant Award Summary Baylor College of Medicine received a $720,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2028. The grant funds research focused on targeting cryptic splicing-derived neoantigens in HNRNPM-dysregulated triple-negative breast cancer. This research initiative represents the DHA's commitment to advancing biomedical solutions relevant to...
- Federal Grant Award Summary Baylor College of Medicine received a $1.62M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct preclinical validation of novel combination therapeutic strategies targeting KRAS and BRAF mutations in colorectal cancer for near-term clinical examination. The award, effective September 1, 2025, with an ultimate completion date of December 14, 2028, supports hypothesis-driven...
- Federal Project Grant Award Summary Baylor College of Medicine was awarded $480,000 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 1, 2025, for a three-year project through August 31, 2028. The research project, titled "Targeting Cryptic Splicing-Derived Neoantigens in HNRNPM-Dysregulated Triple-Negative Breast Cancer," focuses on identifying and developing immunotherapeutic approaches against novel cancer...
- The federal Project Grant award of $1,597,224.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program to support the research project "BCL-XL IN BREAST CANCER METASTASIS AND THERAPY" at Baylor College of Medicine in Houston, Texas. The award, with a performance period from August 1, 2024 to July 31, 2027, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
- This $1,200,000 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Baylor College of Medicine to develop an antibody nanogel that targets bone metastases. The project aims to eliminate bone metastasis, which is a significant challenge in treating various cancers. Baylor College of Medicine, a prestigious non-profit research institution, will conduct this advanced biomedical research over a 3-year...
- This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...
- This $1,600,000.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at Baylor College of Medicine focused on developing new synthetic lethal combination therapies targeting TopBP1 and the arachidonic acid pathway for breast cancer treatment. The three-year award, with an end date of February 28, 2027, will fund basic, translational, and clinical research aimed at advancing scientific understanding and...
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. (DFCI) received a $1.424 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. The award supports research titled "Expanding the Targetable Tumor Antigen Repertoire of Renal Cell Carcinoma," conducted at DFCI's Boston, Massachusetts facility. This research initiative aims to identify and...
- Federal Grant Award Summary The Cleveland Clinic Foundation received a $750,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of April 1, 2026 through March 31, 2029. The award supports research investigating focal adhesion dependencies in CDH1-deficient lobular breast cancers, with performance occurring at the Cleveland Clinic Health System facility in Cleveland, Ohio. This research initiative aligns...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York's Health Sciences Division a $1.645 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research on treating HER2 therapy-resistant brain metastasis using antidepressants, conducted at Columbia's Health Sciences Division facility in New York, NY. This project...